Advertisement

ADVERTISEMENT

Maria Asimopoulos

News
Reversal Agent Results in Promising Hemostatic Outcomes Within 24 Hours of Surgery
10/03/2022
Most patients achieved good or excellent hemostasis after being treated with a modified, recombinant Factor Xa protein to reverse the effects of anticoagulants administered for surgery, findings showed.
Most patients achieved good or excellent hemostasis after being treated with a modified, recombinant Factor Xa protein to reverse the effects of anticoagulants administered for surgery, findings showed.
Most patients achieved good or...
10/03/2022
Veterans Health Today
Headshot of Shawn Kwatra, MD, Johns Hopkins Itch Center, on a blue background underneath the PopHealth Perspectives logo.
Videos
Topical JAK Inhibitor Reduces Itch in Patients With Atopic Dermatitis
09/30/2022
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, shares findings from a recent analysis of two phase 3 trials which investigated the efficacy and safety of a Janus kinase inhibitor for patients with moderate to severe atopic...
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, shares findings from a recent analysis of two phase 3 trials which investigated the efficacy and safety of a Janus kinase inhibitor for patients with moderate to severe atopic...
Shawn Kwatra, MD, FAAD,...
09/30/2022
First Report Managed Care
News
FDA Approves New Treatment for Amyotrophic Lateral Sclerosis
09/30/2022
The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee initially recommended against approving sodium phenylbutyrate/taurursodiol in March but changed their decision after reviewing new data.
The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee initially recommended against approving sodium phenylbutyrate/taurursodiol in March but changed their decision after reviewing new data.
The FDA’s Peripheral and Central...
09/30/2022
First Report Managed Care
Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Drug Spending Trends: Biosimilars, COVID-19 Therapies, and More
09/28/2022
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice...
09/28/2022
Integrated Healthcare Executive
Headshot of Michael Ganio, ASHP, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Monkeypox Vaccines: Current Options, Considerations for Patient Education
09/28/2022
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS,...
09/28/2022
Pharmacy Learning Network
Headshot of Tom Hart, COO, BioCare
Interview
Preventing Supply Chain Delays: Temperature Challenges, Management Strategies
09/27/2022
Tom Hart, chief operating officer, BioCare, reviews the impact of supply chain disruptions on patients and offers advice for managing supply chains better to avoid delays in medication receipt.
Tom Hart, chief operating officer, BioCare, reviews the impact of supply chain disruptions on patients and offers advice for managing supply chains better to avoid delays in medication receipt.
Tom Hart, chief operating...
09/27/2022
Integrated Healthcare Executive
Quiz
Identifying Preferred H2 Blocker for Treating GERD in Breastfeeding Patients
09/26/2022
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor...
09/26/2022
Pharmacy Learning Network
Headshot of Pashtoon Kasi, MD, MS, Weill Cornell Medicine, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Advancements in Colorectal Cancer: Treating Specific Patient Populations
09/23/2022
Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, describes several recent advancements in specific subsets of colorectal cancer and emphasizes the role of biomarker testing for...
Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, describes several recent advancements in specific subsets of colorectal cancer and emphasizes the role of biomarker testing for...
Pashtoon Kasi, MD, MS,...
09/23/2022
First Report Managed Care
News
Treatment Produces Rapid, Sustained Response in Multiple Type 2 Inflammatory Diseases
09/20/2022
Patients with atopic dermatitis, asthma, or chronic rhinosinusitis with nasal polyps saw clinically meaningful improvements in their disease after treatment with a humanized monoclonal antibody.
Patients with atopic dermatitis, asthma, or chronic rhinosinusitis with nasal polyps saw clinically meaningful improvements in their disease after treatment with a humanized monoclonal antibody.
Patients with atopic dermatitis,...
09/20/2022
First Report Managed Care
Headshot of Andrea Ruskin, VA Connecticut Healthcare System
Conference Coverage
The Future of Chronic Pain Management in Patients With Cancer
09/19/2022
Andrea Ruskin, MD, offers insight into her session at the 2022 AVAHO Annual Meeting in which she discussed the use of comprehensive assessments to address chronic pain in patients treated for cancer.
Andrea Ruskin, MD, offers insight into her session at the 2022 AVAHO Annual Meeting in which she discussed the use of comprehensive assessments to address chronic pain in patients treated for cancer.
Andrea Ruskin, MD, offers...
09/19/2022
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use